The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly
Abstract
Purpose This study was performed to determine the effects of markers of inflammation (interleukin 6) and coagulation (D-dimer) on mortality and functional status in older persons.Methods Subjects were selected for the Duke Established Populations for Epidemiologic Studies of the Elderly. In 1992, 2569 subjects (age >71 years) were interviewed, of whom 1,723 had interleukin-6 and D-dimer measurements. Values of interleukin 6 and D-dimer were categorized into quartiles. Outcomes were mortality (through 5 years) and functional status (through 4 years). Relative risks were estimated with proportional hazards models that adjusted for potential confounders.Results The relative risk of mortality was 1.28 (95% confidence interval [CI]: 0.98 to 1.69; P = 0.06) for those with only interleukin-6 levels in the highest quartile, 1.53 (95% CI: 1.18 to 1.97; P = 0.001) for subjects with only D-dimer levels in the highest quartile, and 2.00 (95% CI: 1.53 to 2.62; P = 0.0001) for those with levels of both in the highest quartile, as compared with those who were not in either of the highest quartiles. Those with high interleukin-6 and high D-dimer levels had the greatest declines in all measures of function.Conclusion Activation of the coagulation and inflammatory pathways is associated with mortality and decline in function, and may be part of the explanation for the development of a frailty phenotype in the elderly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In particular, an increase in the basal production of proinflammatory cytokines, observed in different cell types, could be a major contributor to the age-related increase of the levels of such molecules observed in several cohorts of elderly subjects [19, 67, 68].”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [68]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Protective and Damaging Effects of Stress Mediators
McEwen, B. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801153380307 · Cited by 6,733
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J., Laterre, P., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,124
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Hemodynamic shear stress and its role in atherosclerosis
Malek, A. M. (1999) · JAMA · doi:10.1001/jama.282.21.2035 · Cited by 3,650
Quality of life and pharmacoeconomics in clinical trials
Pater, J. L. (1996) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)82191-5 · Cited by 2,410
Danesh, J., Collins, R., Appleby, P. N., & Peto, R. (1998) · JAMA · doi:10.1001/jama.279.18.1477 · Cited by 2,027
Research works printed but not linked: 2
- 1990, Vol. 2
- Sorensen, 2001, A review of the immune system, 55
Cited by
Sorted by citations
Items 201–300 of 326
[Frailty, an enigmatic and controversial concept in geriatrics. The biological perspective].
Ávila‐Funes, J. A., Aguilar-Navarro, S. G., & Melano‐Carranza, E. (2008) · PubMed · Cited by 17
Complicated and complex: Helping the older patient with cancer to exit the labyrinth
Balducci, L., & Aapro, M. (2013) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2013.11.003 · Cited by 15
Supportive care of the older cancer patient
Balducci, L., & Carreca, I. U. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2003.06.001 · Cited by 15
“The response of tumors to chemotherapy and radiotherapy may be compromised in the presence of anemia, because the anoxia of the tumor tissue prevents the formation of free radicals necessary to the damage of the neoplastic DNA ( 5 ) . Symptomatic anemia requires management of blood transfusions that have been associat…”
BackgroundTHE USE OF IMMUNOCOMPROMISED ANIMALS AS MODELS FOR HUMAN SEPTIC SHOCK
Opal, S. M., & Cross, A. S. (2005) · Shock · doi:10.1097/01.shk.0000191335.93412.3e · Cited by 15
Aging in the context of cancer prevention and control
Bellizzi, K. M., Mustian, K. M., Bowen, D. J., Resnick, B. M., & Miller, S. M. (2008) · Cancer · doi:10.1002/cncr.23937 · Cited by 14
Vidal, K., Breuillé, D., Serrant, P., Denis, P., Glomot, F., Béchereau, F., & Papet, I. (2013) · European Journal of Nutrition · doi:10.1007/s00394-013-0600-0 · Cited by 15
Treating elderly patients with hormone sensitive breast cancer: What do the data show?
Balducci, L. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.08.001 · Cited by 14
Reed, R. G., Greenberg, R. N., & Segerstrom, S. C. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.09.025 · Cited by 13
Leng, S. X., Dandorf, S., Li, H., Carlson, J., Hui, J., Mehta, S. H., Piggott, D. A., Islam, S., Manwani, B., & Kirk, G. D. (2015) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2015.0134 · Cited by 13
Social Justice and Equity: Why Older Adults With Cancer Belong—A Life Course Perspective
Yilmaz, S., Sanapala, C., Schiaffino, M. K., Schumacher, J. R., Wallington, S. F., McKoy, J. M., Canin, B. E., Tang, W., Tucker‐Seeley, R. D., Simmons, J., et al. (2022) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_349825 · Cited by 13
Nüesch, E., Dale, C. E., Amuzu, A., Kuper, H., Bowling, A., Ploubidis, G. B., Lowe, G. D. O., Rumley, A., Ebrahim, S. B. J., & Casas, J. P. (2012) · European Journal of Epidemiology · doi:10.1007/s10654-012-9706-6 · Cited by 12
DNA damage, inflammation and aging: Insights from mice
Arvanitaki, E. S., Stratigi, K., & Garinis, G. A. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.973781 · Cited by 14
“, IL-6, clotting factors and acute phase reactants (Ferrucci et al., 1999; Cohen et al., 2003; Cavanagh et al., 2012; Shaw et al., 2013).”
BackgroundBiologic Mechanisms Linked to Prognosis in Ovarian Cancer that May Be Affected by Aging
Chon, H. S., Sehovic, M., Marchion, D. C., Walko, C. M., Xiong, Y., & Extermann, M. (2019) · Journal of Cancer · doi:10.7150/jca.29611 · Cited by 12
“For example, IL-6 and D-dimers correlated with higher mortality at 5 years and decrease function at 4 years [57].”
BackgroundNielson, C., & Wingete, D. (2004) · Chronic Respiratory Disease · doi:10.1191/1479972304cd012rs · Cited by 12
Noppert, G. A., Aiello, A. E., O'Rand, A. M., & Cohen, H. J. (2018) · Epidemiology and Infection · doi:10.1017/s095026881800153x · Cited by 11
“This approach has been used in other bio-marker studies [17].”
Self-citationKirk, G. D., Dandorf, S., Li, H., Chen, Y., Mehta, S. H., Piggott, D. A., Margolick, J. B., & Leng, S. X. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01343 · Cited by 11
(2007) · Apmis · doi:10.1111/j.1600-0463.2007.00840.x · Cited by 11
“The precision and clarity in definition of this tool is attractive, and it appears to correlate with specific physiological alterations, particularly enhanced inflammation and coagulation [15], as have other measures [ 16 , 17].”
BackgroundOwusu, C., Nock, N. L., Hergenroeder, P., Austin, K., Bennet, E., Cerne, S., Moore, H. C. F., Petkac, J., SCHLUCHTER, M. D., Schmitz, K. H., et al. (2020) · Contemporary Clinical Trials · doi:10.1016/j.cct.2020.106001 · Cited by 11
Inflammation and hemostasis in older octogenarians: implication in 5-year survival
Cubedo, J., Padró, T., Formiga, F., Ferrer, A., Padrós, G., Peña, E., & Badimón, L. (2017) · Translational research · doi:10.1016/j.trsl.2017.04.003 · Cited by 10
Reno, T. A., Tarnus, L., Tracy, R. P., LANDAY, A. L., Sereti, I., Apetrei, C., & Pandrea, I. (2022) · Frontiers in Virology · doi:10.3389/fviro.2021.795373 · Cited by 9
“The inflammatory effects of C5a include, but are not limited to, recruitment of the immune effectors (macrophages, monocytes, dendritic cells, neutrophils, lymphocytes), activation of neutrophils, which result in enhanced production of the inflammatory cytokines IL-6 and TNF-α, increases in vascular permeability and t…”
InfluentialJeong, S. J., Han, S. H., Kim, C. O., Choi, J. Y., Song, Y. G., & Kim, J. M. (2014) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12428 · Cited by 9
Advanced Non–Small-Cell Lung Cancer in the Elderly
Vamvakas, L. N., Saloustros, E. S., Karampeazis, A., & Georgoulias, V. (2009) · Clinical Lung Cancer · doi:10.3816/clc.2009.n.022 · Cited by 9
Sullivan, M. J., Carey, A. J., Leclercq, S. Y., Tan, C. K., & Ulett, G. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167732 · Cited by 8
“However, in contrast to prior studies that report high levels of IL-6 in elderly adults compared to younger adults [46, 49, 50], we failed to detect a statistically significant difference in the levels of IL-6 between young mice and aged mice in the current study (medians: young 95 pg/mL vs.”
ResultAccuracy of D-Dimers to Rule Out Venous Thromboembolism Events across Age Categories
Sahakian, G. D., Claessens, Y.-É., Allo, J.-C., Kansao, J., Kierzek, G., & Pourriat, J.-L. (2010) · Emergency Medicine International · doi:10.1155/2010/185453 · Cited by 8
“However, interpretation of D-dimers level is altered in older patients, as ageing or underlying clinical conditions may activate coagulation.”
BackgroundTakahashi, K., Umemura, Y., Yamakawa, K., Ogura, H., & Shimazu, T. (2021) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296211033030 · Cited by 8
“Outcomes ICU length (days) 9 (5-15) 5 (3-11) <0.”
Balducci, L. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00063-1 · Cited by 8
Biological Basis of Cancer in the Older Person
Beghé, C., & Balducci, L. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-387-23962-6_10 · Cited by 8
Impact and treatment of anemia in the elderly: clinical, epidemiological and economic perspectives
Duh, M. S., Latypova, A., & Greenberg, P. E. (2006) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.6.5.577 · Cited by 7
Supportive Care of Elderly Patients with Cancer
Balducci, L. (2005) · Supportive Cancer Therapy · doi:10.3816/sct.2005.n.015 · Cited by 7
Zuo, X., Luciano, A., Pieper, C. F., Bain, J. R., Kraus, V. B., Kraus, W. E., Morey, M. C., & Cohen, H. J. (2018) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15393 · Cited by 7
“Some markers, such as D-dimer and IL-6, have been modestly associated with mortality and poor physical performance.(7,28,29) They were present in the robustness and impairment indices, suggesting that their relationship with a spectrum of function may be more linear than other markers that preferentially predict only…”
BackgroundSelf-citationZhu, C., Hou, Z., Zhu, R., Zhou, B., Sun, Y., Li, Z., Li, X., Ding, R., Luan, Z., Liang, Y., et al. (2023) · Surgery · doi:10.1016/j.surg.2023.01.002 · Cited by 6
Health Outcomes Associated with Self-Reported Vision Impairment in Older Adults
Steinman, B. A. (2016) · Journal of Visual Impairment & Blindness · doi:10.1177/0145482x1611000602 · Cited by 6
Wang, X., You, T., Yang, R., Lyles, M. F., Demons, J. L., Gong, D.-W., & Nicklas, B. J. (2010) · Age and Ageing · doi:10.1093/ageing/afq024 · Cited by 6
Target practice: Opportunities for therapeutic intervention in CHIP and CCUS
Mohammad, A., Mascarenhas, J. O., Marcellino, B. K., & Nathan, D. I. (2025) · Blood Reviews · doi:10.1016/j.blre.2025.101323 · Cited by 5
Ko, F., & Walston, J. D. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-3796-7.00063-x · Cited by 5
Stanifer, J. W., Landerman, L. R., Pieper, C. F., Huffman, K. M., & Kraus, W. E. (2017) · Clinical Kidney Journal · doi:10.1093/ckj/sfx097 · Cited by 5
“IL-6, D-dimer and s-VCAM all are associated with functional disabilities in elderly populations [15, 16, 20, 36].”
BackgroundSelf-citationAyari, F., Chaaben, A. B., Ammar, H. B., Nefzi, R., Ouni, N., Mihoub, O., Abaza, H., Aissa, A., Douik, H., Gara, S., et al. (2020) · L Encéphale · doi:10.1016/j.encep.2019.10.001 · Cited by 5
Cost of cancer clinical trials in elderly patients
Balducci, L. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.3.505 · Cited by 5
“A recent study has shown that both the concentration of IL-6 and D-dimer in the circulation of home-dwelling older individuals are predictive of these outcomes [31].”
BackgroundHurria, A., Muss, H. B., & Cohen, H. J. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm074 · Cited by 5
Self-citationDeveloping interferon-β as a safe in vivo experimental-medicine model of human inflammation
Periche-Tomas, E., Underwood, J., MacIver, C., Leach, H., Bone, C., Guy, C., Triantafilou, K., Szomolay, B., Jones, S. A., & Harrison, N. A. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106173 · Cited by 4
Jiang, W., Jia, W., & Dong, C. (2024) · Thrombosis Journal · doi:10.1186/s12959-024-00599-3 · Cited by 4
“…showed that the average age of patients with CTD-ILD was 55.6 years old [143], with increasing age, the balance of coagulation factors and coagulation inhibitors in the patient’s body will change [144], and the coagulation pathway is activated [145] making the blood in a hypercoagulable state.”
BackgroundInfluentialArrieta, E., Lalueza, A., García, B. A., Trujillo, H., Folgueira, M. D., Paredes, D., Verdejo, M. Á., Camacho, J., Caso, J. M., Heredia, C., et al. (2021) · Gerontology · doi:10.1159/000519157 · Cited by 4
Gilmore, N. J., Loh, K. P., Liposits, G. I., Arora, S. P., Vertino, P. M., & Janelsins, M. C. (2023) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2023.101655 · Cited by 4
Yuan, Y., Vora, N. L., Sun, C., Li, D., Smith, D. D., Mortimer, J. E., Luu, T. H., Somlo, G., Waisman, J. R., Chao, J., et al. (2017) · The Oncologist · doi:10.1634/theoncologist.2016-0391 · Cited by 4
“There are several studies reported in the geriatric literature demonstrating an association between elevated markers of chronic inflammation (IL-6 and CRP) and coagulation factor (Ddimer) with physical functional decline and increased risk of mortality [6, 7, 9, 11, 13, 14].”
Diego, V. P., Almasy, L. A., Rainwater, D. L., Mahaney, M. C., Comuzzie, A. G., Cole, S. A., Tracy, R. P., D, M. P. S. M., MacCluer, J. W., & Blangero, J. (2010) · International Journal of Vascular Medicine · doi:10.1155/2010/490241 · Cited by 4
“Hindawi Publishing Corporation International Journal of Vascular Medicine Volume 2010, Article ID 490241, 6 pages doi:10.1155/2010/490241 Research Article”
InfluentialMayot, G., Vidal, K., Combaret, L., Breuillé, D., Blum, S., Obled, C., & Papet, I. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2007.09.002 · Cited by 4
“Age-associated increase 58 in the levels of inflammatory markers, such as interleukin-6 (IL-6) and CRP, are associated 59 with disability and mortality (Ferrucci et al., 1999; Harris et al., 1999; Ferrucci et al., 2002; 60 Cohen et al., 2003).”
BackgroundOral anticoagulants in older adults with atrial fibrillation
Bernacki, G. M., & Becker, R. C. (2013) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-013-0869-0 · Cited by 3
Transitions to Family Caregiving and Latent Variables of Systemic Inflammation Over Time
Roth, D. L., Bentley, J. P., Mukaz, D. K., Haley, W. E., Walston, J. D., & Bandeen‐Roche, K. (2022) · Research on Aging · doi:10.1177/01640275221084729 · Cited by 3
“D-dimer is generated from clottingrelated processes and has been utilized as a surrogate marker of inflammation inmany population studies of older adults (Cohen et al., 2003; Walston et al., 2002).”
MethodKetkar, H., Alqahtani, M., Tang, S., Parambath, S. P., Bakshi, C. S., & Jain, S. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1173577 · Cited by 3
“Immune dysfunctions associated with immuosenescence include defects in T and B cell development resulting in impaired innate and adaptive immune responses to pathogens and immunogens (Cohen et al., 2003; Arnold et al., 2011; Kogut et al., 2012).”
BackgroundAge barriers in allogeneic hematopoietic cell transplantation: Raising the silver curtain
Munshi, P. N., & McCurdy, S. R. (2024) · American Journal of Hematology · doi:10.1002/ajh.27228 · Cited by 3
“114,115 For instance, endothelial markers of dysfunction, such as vascular cell adhesion molecule (s-VCAM), D-dimer, and IL-6, were independently associated with 4-year mortality after adjusting for functional status, demo-graphics, and comorbidities.”
BackgroundChapagai, S., Harrington, K. A., Alexandria, S. J., Vu, T. T., Khan, S. S., Carnethon, M. R., & Knutson, K. L. (2025) · SLEEP · doi:10.1093/sleep/zsaf020 · Cited by 3
Koll, T. T., Magnuson, A. M., Dale, W., LaBarge, M. A., Leach, C. R., Mohile, S. G., Muss, H. B., Sedenquist, M., & Klepin, H. D. (2019) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2019.09.006 · Cited by 3
Anemia and Aging or Anemia of Aging?
Balducci, L., & Aapro, M. (2007) · Springer eBooks · doi:10.1007/978-0-387-49506-4_2 · Cited by 3
“demonstrated that increased concentrations of IL-6 and D-Dimer in the circulation of home-dwelling individuals aged 70 and over were associated with increased risk of mortality and functional decline (25).”
BackgroundRecomendaciones para el tratamiento del cáncer en el anciano: implicaciones para la calidad de vida
Balducci, L. (2004) · Revista Española de Geriatría y Gerontología · doi:10.1016/s0211-139x(04)74969-0 · Cited by 3
Has dysregulated interleukin-6 gene a role in the development of Alzheimer's disease?
Capurso, C. A. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.08.038 · Cited by 3
Inflammation and coagulation: direct mediators of physical function in the elderly?
Marenberg, M. E. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00039-1 · Cited by 3
La fragilité des personnes âgées
Lang, P. O. (2013) · Presses de l’EHESP eBooks · doi:10.3917/ehesp.bela.2013.01.0067 · Cited by 4
Role of Immunosenescence in Infections and Sepsis in the Elderly
Fülöp, T., Castle, S. C., Larbi, A., Fortin, C. F., Lesur, O., & Pawelec, G. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9063-9_48 · Cited by 3
“Indeed Cohen et al. [ 46 ] have reported that activation of the coagulation (D-dimer) and the inflammatory (IL-6) pathway at baseline is associated with mortality and decline in function.”
BackgroundBiological Basis of the Association of Cancer and Aging Comorbidity
Extermann, M. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-387-23962-6_9 · Cited by 3
La fragilité : mythe ou réalité ?
Lang, P.-O., Trivalle, C., & Dramé, M. (2012) · NPG. Neurologie, psychiatrie, gériatrie/NPG · doi:10.1016/j.npg.2012.04.007 · Cited by 4
Environmental Influences on the Immune System: The Aging Immune System
Mälzer, J. N., Schulz, A. R., & Thiel, A. (2016) · Springer eBooks · doi:10.1007/978-3-7091-1890-0_3 · Cited by 2
Soto‐Pérez‐de‐Celis, E., & Hurria, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00060-8 · Cited by 2
Role of Immunosenescence in Infections and Sepsis in the Elderly
Lesur, O., Fülöp, T., Castle, S. C., Larbi, A., Fortin, C. F., & Pawelec, G. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_48 · Cited by 2
Geriatric assessment for the older adult with cancer
Hurria, A., & Cohen, H. J. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511763182.001 · Cited by 2
Self-citationPathogenic SIV infection is associated with acceleration of epigenetic age in rhesus macaques
Jasinska, A. J., Sivanandham, R., Sivanandham, S., Xu, C., Gordevičius, J., Milčiūtė, M., Brooke, R. T., Sette, P., He, T., Brocca‐Cofano, E., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci189574 · Cited by 1
“…with alteration of hemostasis regulation, leading to hypercoagulation and prothrombotic states (10, 11), with heightened risks for venous thrombosis, complicated or severe atherosclerosis, and pulmonary emboli (10), and may affect the long-term outcomes of diseases in the elderly (10, 11).”
Ren, Z.-F., Huang, J.-J., Xin, K., Yang, Z.-J., Li, D.-Z., Chen, Y., Guan, Y.-H., Liu, Z., & Wu, M. T. (2025) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296251386049 · Cited by 1
Frailty and stem cell transplantation in the older patient with cancer
Morris, G. S., Bordes, J. D., Holmes, H. M., & Giralt, S. A. (2012) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2012.03.001 · Cited by 1
Brain, E. G. C. (2006) · Psycho-Oncologie · doi:10.1007/s10332-006-0139-x · Cited by 1
Kamiya, Y., Timonen, V., Romero‐Ortuño, R., & Kenny, R. A. (2013) · Springer eBooks · doi:10.1007/978-94-007-6140-7_18 · Cited by 1
Aires, A., & Júnior, P. (2014) · Cited by 1
Profil biologique des patients âgés fragiles
Célarier, T., Chol, C., & Gonthier, R. (2009) · Springer eBooks · doi:10.1007/978-2-287-93911-2_3 · Cited by 1
Cancer in the Elderly: Biology, Prevention, and Treatment
Balducci, L., & Beghé, C. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50071-3 · Cited by 1
Sandoval-Valdez, D. A., & Aguilar-Navarro, S. G. (2023) · Gaceta Médica de México · doi:10.24875/gmm.m23000822 · Cited by 1
Girard, T. D., Opal, S. M., & Ely, E. W. (2005) · Springer eBooks · doi:10.1007/0-387-26272-5_38 · Cited by 1
“Additionally, the monocytes of healthy elderly adults demonstrate increased intracellular levels of TNF-a, IL-1, and IL-6 [21] , and increasing age is associated with rising circulating levels of IL-6 and D-dimer [22] , activated Factor VII, and other coagulation factors [23] , indicating activation of inflammatory an…”
BackgroundPinti, M., Biasi, S. D., Gibellini, L., Tartaro, D. L., Gaetano, A. D., Mattioli, M., Fidanza, L., Nasi, M., & Cossarizza, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822569-1.00008-1 · Cited by 1
Supportive Care of the Older Cancer Patient
Balducci, L. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-291-5_14 · Cited by 1
Biomarcadores en paciente frágil: una revisión exploratoria
Barbosa, F. R., Londoño, F. G., Ospina-Gómez, S., González, J. S. S., & Bastidas, A. (2022) · Gaceta Médica de Caracas · doi:10.47307/gmc.2022.130.1.14 · Cited by 1
Senior Adult OncologyPractice Guidelines in Oncology
Hurria, A., Browner, I. S., Cohen, H. J., Denlinger, C. S., deShazo, M., Extermann, M., Ganti, A. K., Ganti, P., Holland, J. C., Holmes, H. M., et al. (2012) · Cited by 1
Self-citationMeldrum, C. A. (2014) · Deep Blue (University of Michigan)
Challenges of Geriatric Oncology
Balducci, L. (2007) · Springer eBooks · doi:10.1007/978-88-470-0552-5_53
Balducci, L. (2014) · doi:10.1002/9781118833391.ch19
Cytokines and Disability in Older Adults
Thomas, D. R. (2007) · Springer eBooks · doi:10.1007/978-88-470-0552-5_39
Chronic low-grade inflammation, lipid risk factors and mortality in functionally dependent elderly
Vasović, O., Trifunović, D., Despotovic, N., & Milosevic, D. P. (2010) · Vojnosanitetski pregled · doi:10.2298/vsp1007562v
Aging and High-Density Lipoprotein Metabolism
Arai, Y., & Hirose, N. (2006) · Aging Health · doi:10.2217/1745509x.2.4.611
Wollner, D. I. (2005) · NPG. Neurologie, psychiatrie, gériatrie/NPG · doi:10.1016/s1627-4830(05)82578-4
Biologische risicofactoren voor kwetsbaarheid
Puts, M. T. E., & Deeg, D. J. H. (2006) · Bijblijven · doi:10.1007/bf03059967
Martínez-Huenchullán, S., & Solorza, E. M. (2015) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2015.03.004
Physiological Consequences of Aging
Kanapuru, B., & Ershler, W. B. (2009) · Springer eBooks · doi:10.1007/978-0-387-89070-8_4
Racial Comparison of D-Dimer Levels in Adults Before and After HIV Infection
O’Bryan, T. A., Freiberg, M. S., Tracy, R. P., So‐Armah, K., Okulicz, J. F., Ganesan, A., Lalani, T., Armstrong, A. W., Rimland, D., Deiss, R., et al. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv133.1206
Health Status Screening in Elderly Patients — Is this the Way Forward?
Kaźmierska, J. (2012) · European Oncology & Haematology · doi:10.17925/eoh.2012.08.01.63
Aging, Cancer, and Translational Research
Balducci, L. (2007) · Translational medicine series · doi:10.3109/9781420019940.006
Research Methods: Translational Research in Geriatric Oncology
Williams, G. R., Muss, H. B., & Shachar, S. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-44870-1_3-1
Carranco-Medina, T. E. (2017) · Gredos (University of Salamanca) · doi:10.14201/gredos.135753
Tampubolon, G., & Fajarini, M. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/268334
Biomarkers of Aging (With a Clinical Potential in Oncology)
Hubbard, J. M. (2020) · Springer eBooks · doi:10.1007/978-3-319-57415-8_62
Commentary (Balducci): Ovarian Cancer in Elderly Women
Balducci, L. (2003)
Zadvorev, S. F., Zamytskaia, A., Пискунов, Д. П., Pushkin, A. S., & Yakovlev, A. A. (2020) · Advances in Gerontology · doi:10.1134/s2079057020010166
Metadata
- Authors
- Cohen, H. J., Harris, T., & Pieper, C. F.
- Affiliations
- Duke University (US)
- National Institutes of Health (US)
- Corresponding author
- Cohen, Harvey Jay
- Venue
- The American Journal of Medicine
- Publisher
- Elsevier BV
- Published
- 2003-02
- Volume
- 114
- Issue
- 3
- Pages
- 180-187
- ISSN
- 0002-9343 (ISSN-L)
- OpenAlex
- W1994696327
- Cited by
- 327
- References
- 53
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 6 · 2023: 6 · 2022: 14 · 2021: 7 · 2020: 9 · 2019: 6 · 2018: 7 · 2017: 13 · 2016: 19 · 2015: 14 · 2014: 18 · 2013: 19 · 2012: 19
- FWCI
- 10.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01ag012102-011)
- National Institute on Aging (R01AG012765, N01‐AG12102, P60AG011268)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Aging, Health, and Disability
- Keywords
- interleukin-6, D-dimer, coagulation, inflammation, mortality, functional decline, frailty, older adults, inflammatory markers
- MeSH terms
- Activities of Daily Living, Aged, Aged, 80 and over, Black or African American, Blood Coagulation, Cardiovascular Diseases, Cause of Death, Diabetes Mellitus, Female, Fibrin Fibrinogen Degradation Products, Humans, Inflammation, Longitudinal Studies, Male, Neoplasms, North Carolina, Smoking, Biomarkers, Interleukin-6, Multivariate Analysis, Frail Elderly, Sex Distribution, Pulmonary Disease, Chronic Obstructive, Black People, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
